The Biden administration has been pushing to make boosters available to all American adults since the summer
Photo: Lane Turner/The Boston Globe via Getty Images The Food and Drug Administration is planning to authorize booster shots of Pfizer’s COVID vaccine for all American adults as soon as Thursday, according to people familiar with the agency’s plans who spoke with the New York Times.
The FDA’s plan to rapidly authorize boosters for all adults comes as a number of states and localities have already independently made that shift. Over the past week, Arkansas, California, Colorado, New Mexico, West Virginia, and New York City have all announced that they are encouraging booster shots for all adults who received a full COVID vaccination at least six months ago. Those expansions of eligibility went beyond the current recommendations of federal regulators.
— despite reservations from some scientists that this wasn’t yet necessary. But the FDA and CDC have thus far signed off only on the extra shots for seniors; people who are at higher risk of severe illness from COVID ; recipients of the single-dose Johnson & Johnson vaccine; and anyone who self-identified as being at higher risk of exposure to COVID, like frontline workers.
FDA authorization of boosters for all adults would undoubtedly simplify public-health guidance and reduce confusion regarding the matter.
South Africa Latest News, South Africa Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Pfizer asks FDA to authorize Covid antiviral pillsPfizer asked the FDA to authorize its oral Covid antiviral pill called Paxlovid. The treatment is highly effective in reducing the risk of hospitalization.
Read more »
FDA expected to authorize Pfizer COVID-19 booster for all adults this weekThe move could come as early as Thursday.
Read more »
Pfizer Seeks FDA Emergency Use Authorization for Its COVID-19 PillPfizer has signed a deal to allow other manufacturers to make its experimental COVID-19 pill, possibly opening up access to treatment to countries across the world:
Read more »
Pfizer seeks FDA emergency use authorization for its experimental Covid-19 antiviral pillPfizer announced Tuesday that it is seeking emergency use authorization from the US Food and Drug Administration for its experimental antiviral Covid-19 pill, known as PF-07321332 or Paxlovid.
Read more »
Philips shares tumble as FDA raises concern about silicone foamKoninklijke Philips undefinedundefined was on track for its worst single session in 19 years, falling 9.6%, after the Food and Drug Administration's...
Read more »